Tocilizumab-induced Leukoencephalopathy with a Reversible Clinical Course-Reference-Cited by-同舟云学术

Tocilizumab-induced Leukoencephalopathy with a Reversible Clinical Course

Published:2020-11-15 Issue:22 Volume:59 Page:2927-2930
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Sasaki Ryo¹,Hishikawa Nozomi¹,Nomura Emi¹,Omote Yoshio¹,Takemoto Mami¹,Yamashita Toru¹,Hatanaka Noriko²,Higashi Yasuto²,Abe Koji¹

Affiliation:

1. Department of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Japan

2. Department of Neurology, Himeji Central Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/59/22/59_5288-20/_pdf

Reference11 articles.

1. 1. Biggioggero M, Crotti C, Becciolini A, Favalli EG. Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection. Drug Des Devel Ther 13: 57-70, 2018.

2. 2. Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J. Tocilizumab treatment in COVID-19: a single center experience. J Med Virol 10: 1002, 2020.

3. 3. Ogata A, Kato Y, Higa S, Yoshizaki K. IL-6 inhibitor for the treatment of rheumatoid arthritis: a comprehensive review. Mod Rheumatol 29: 258-267, 2019.

4. 4. Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol 6: a016295, 2014.

5. 5. Narazaki M, Kishimoto T. The two-faced cytokine IL-6 in host defense and diseases. Int J Mol Sci 19: 3528, 2018.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploratory assessment of the effect of systemic administration of soluble glycoprotein 130 on cognitive performance and chemokine levels in a mouse model of experimental traumatic brain injury;Journal of Neuroinflammation;2024-06-05

2. A comprehensive review of imaging findings in COVID-19 - status in early 2021;European Journal of Nuclear Medicine and Molecular Imaging;2021-05-01

3. Drug-Induced Encephalopathies;Drug-induced Neurological Disorders;2021

4. Tacrolimus/tocilizumab interaction;Reactions Weekly;2020-12

5. Implications for White Matter Vulnerability to Anti-interleukin-6 Receptor Antibody Treatment;Internal Medicine;2020-11-15